Accelerated long-term forgetting

Biomarker

1 paper3 findings

  • Humans1

Upstream

1

Autosomal dominant Alzheimer's disease mutation

downin humans1

1 study
  1. Autosomal dominant Alzheimer's disease mutation impairs accelerated long-term forgetting in humans.

    “ALF test score was significantly lower in mutation carriers than non‐carriers across the three tests.”

    Humansin presymptomatic ADAD mutation carriers vs non-carriers

    Neuroimaging correlates and prognostic utility of accelerated long‐term forgetting in presymptomatic autosomal dominant Alzheimer's disease

    AAIC 2025 abstract25 Dec 2025

Associations

2

Alzheimer's disease symptom onset

upin humans1

1 study
  1. Accelerated long-term forgetting predicts Alzheimer's disease symptom onset in humans (AUC=0.82 (story), AUC=0.73 (list)).

    “Story ALF (AUC=0.82) and list ALF (AUC=0.73) discriminated between those who did and did not develop symptoms.”

    Humanspredicting symptom onset in mutation carriersmedian 7 years

    Neuroimaging correlates and prognostic utility of accelerated long‐term forgetting in presymptomatic autosomal dominant Alzheimer's disease

    AAIC 2025 abstract25 Dec 2025

More on Alzheimer's disease symptom onset

Prefrontal cortex cortical thickness

downin humans1

1 study
  1. Accelerated long-term forgetting is associated with prefrontal cortex cortical thickness in humans.

    “In mutation carriers, verbal ALF (list and story) was associated with lower baseline cortical thickness in the prefrontal cortex (PFC) across four contiguous regions bilaterally”

    Humansin presymptomatic ADAD mutation carriersprefrontal cortex

    Neuroimaging correlates and prognostic utility of accelerated long‐term forgetting in presymptomatic autosomal dominant Alzheimer's disease

    AAIC 2025 abstract25 Dec 2025

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months